Chemical engineering

Writing for Scientific American, Carolyn Barber spotlights how researchers from MIT are developing cheap, fast and easy to use diagnostics for Covid-19 that can deliver results in minutes. “They are called lateral flow assays, but manifestly they are paper-strip tests that have an antibody embedded on filter paper,” writes Barber. “If a saliva sample has coronavirus present, the antibody will bind that viral antigen, turning the test positive, much like a pregnancy test works.”

Reporting for USA Today, Karen Weintraub spotlights how researchers from MIT and 3M are collaborating on a rapid, low-cost diagnostic test for Covid-19. "The world needs as many useful tests as possible as fast as possible," says Prof. Hadley Sikes.

CNBC reporter Will Feur spotlights how researchers from MIT are working with 3M on developing a rapid coronavirus antigen test. The test “will be a paper-based point-of-care testing device, which will help reduce the cost,” Feur explains.

Researchers from MIT and 3M are developing a new rapid antigen test for Covid-19, reports Carl O’Donnell for Reuters. “The test would produce results within minutes and could be administered on a low-cost, paper-based device, similar to a home pregnancy test, that could be delivered at the point of care,” writes O’Donnell.

TechCrunch reporter Darrell Etherington writes that researchers from MIT and 3M are working on creating a new diagnostic tool for Covid-19 that can be manufactured cheaply and in large volumes for mass distribution. “The goal is to create a test that detects viral antigens,” Etherington explains, adding that the tests “provide results much faster than the molecular PCR-based test.”

MIT researchers have developed a skin patch that could be used to fight melanoma, reports Berkeley Lovelace Jr. for CNBC. “Our patch technology could be used to deliver vaccines to combat different infectious diseases,” explains Prof. Paula Hammond. “But we are excited by the possibility that the patch is another tool in the oncologists’ arsenal against cancer, specifically melanoma.”

Writing for Science, Derek Lowe spotlights how MIT researchers are developing a platform that could be used to automate the production of molecules for use in medicine, solar energy and more. “The eventual hope is to unite the software and the hardware in this area,” reports Lowe, “and come up with a system that can produce new compounds with a minimum of human intervention.”

Dr. Francis Collins, director of the NIH, spotlights a video created by Prof. Kwanghun Chung that takes viewers on a voyage through a region of the brain that controls voluntary movement. Thanks to imaging techniques like Chung’s, “mapping the biocircuitry of the brain just keeps getting better all the time,” Collins explains.

Writing for the Financial Times about how technology is advancing the field of health care, John Browne spotlights Prof. Bob Langer’s work developing new methods of delivering drugs with improved precision. Browne explains that Langer is working on “a device smaller than a grain of rice that he can inject into a tumour to test the efficacy of dozens of chemotherapy agents in parallel.”

Writing for Scientific American, Prof. Bob Langer examines how breakthroughs in biotechnology and materials science are enabling more personalized and effective treatments for patients. Langer highlights how by “engineering polymers that offer smart delivery systems, we can target specific parts of the body. This limits exposure and therefore adverse effects, offering more effective and precise treatment.”

President Emerita Susan Hockfield discusses her new book, “The Age of Living Machines,” her work as a neuroscientist, and the future of science and technology during a curated lunch conversation with HUBweek and Boston.com. Hockfield explains that a revolution spurred by the convergence of biology with engineering will lead to new technologies built by biology.

In an excerpt from her new book published in The Wall Street Journal, President Emerita Susan Hockfield explores how the convergence between biology and engineering is driving the development of new tools to tackle pressing human problems. Hockfield writes that for these world-changing technologies to be realized requires “not only funding and institutional support but, more fundamentally, a commitment to collaboration among unlikely partners.”

President Emerita Susan Hockfield speaks with Jim Braude of WGBH’s Greater Boston about her book, “The Age of Living Machines.” “We are looking at a population of over 9.7 billion by 2050,” explains Hockfield. “We are not going to get there without war or epidemics or starvation if we don’t develop technologies that will allow us to provide energy, food, water, health and health care sustainably.”

Verge reporter Angela Chen spotlights Prof. Michael Strano’s work using nanobionics to engineer plants. “It’s long overdue that we start to look at plants as the starting point of technology,” explains Strano. “As an engineering platform, they have a number of untapped advantages.”

MIT researchers have developed a new drug-releasing coil that could be used to help treat tuberculosis, reports Ruby Prosser Scully for New Scientist. Scully explains that the coil is “too large to leave the stomach, so it stays there, and the medicines threaded onto it leach out at a rate depending on the type of drug and the polymer the developers use to make the pills.”